 BILLERICA, Mass.--BUSINESS WIRE--Quanterix Corporation NASDAQ:QTRX, a company digitizing biomarker analysis to advance the science of precision health, today announced that its Simoa technology has been used in research studies to detect the SARS-CoV-2 virus in serumplasma, dried blood microsamples DBS and saliva samples obtained from polymerase chain reaction PCR COVID-19 patients. Published in Nature Communications, the research study of these technologies offers further evidence t 